VOROLANIB
|
|
|
- CAS号:
- 1013920-15-4
- 英文名:
- X-082
- 英文别名:
- X82;X-82;X 82;CM082;X-082;CM-082;CM 082;Vorolanib;X-82 (Vorolanib);1H-Pyrrole-3-carboxamide, N-[(3S)-1-[(dimethylamino)carbonyl]-3-pyrrolidinyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- 中文名:
- VOROLANIB
- 中文别名:
- 化合物VOROLANIB;X-82 (VOROLANIB);N-[(3S)-1-[(二甲氨基)羰基]-3-吡咯烷基]-5-[(Z)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-2,4-二甲基-1H-吡咯-3-甲酰胺
- CBNumber:
- CB33126649
- 分子式:
- C23H26FN5O3
- 分子量:
- 439.48
- MOL File:
- 1013920-15-4.mol
|
|
|
VOROLANIB化学性质
-
沸点:
-
657.8±55.0 °C(Predicted)
-
|
-
密度:
-
1.37±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO: 27 mg/mL (61.44 mM)
-
|
-
酸度系数(pKa):
-
11.70±0.20(Predicted)
-
|
VOROLANIB性质、用途与生产工艺
X-82 (Vorolanib, CM082)是一种口服的 vascular endothelial growth factor receptor (VEGFR) 和 platelet-derived growth factor receptor (PDGFR) 的多激酶双重抑制剂，并具有抗血管生成和抗肿瘤的活性。
| Target | Value |
VEGFR
()
|
PDGFR
()
|
VOROLANIB
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-109019 | Vorolanib | | 1 mg | 1142元 |
| 2024/01/25 | HY-109019 | VOROLANIB
Vorolanib | 1013920-15-4 | 5mg | 3000元 |
1013920-15-4, VOROLANIB 相关搜索:
- 合成有机化合物配体
- X-82 (VOROLANIB)
- N-[(3S)-1-[(二甲氨基)羰基]-3-吡咯烷基]-5-[(Z)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-2,4-二甲基-1H-吡咯-3-甲酰胺
- 化合物VOROLANIB
- 1013920-15-4
- X-82 (Vorolanib)
- VEGFR,PDGFR,X82,Vascular endothelial growth factor receptor,CM 082,transporter,angiogenesis,CM-082,X 82,Vorolanib,ATP-binding,tyrosine,ABC,Inhibitor,ABCG2,inhibit,Platelet-derived growth factor receptor,TKI,cassette,orally,kinase,HUVECs
- 1H-Pyrrole-3-carboxamide, N-[(3S)-1-[(dimethylamino)carbonyl]-3-pyrrolidinyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- X-82
- X82
- X 82
- Vorolanib
- CM-082
- CM082
- CM 082
- X-082